{"pub": "investing.com", "url": "https://investing.com/news/stock-market-news/eli-lilly-reports-9-rise-in-thirdquarter-profit-2002044", "downloaded_at": "2019-10-23 10:52:58.646866+00:00", "title": "Eli Lilly reports 9% rise in third-quarter profit", "language": "en", "text": "Eli Lilly reports 9% rise in third-quarter profit\n\nStock Markets 16 minutes ago (Oct 23, 2019 06:37AM ET)\n\n(Reuters) - Eli Lilly and Co (N: ) reported a 9.1% increase in third-quarter profit on Wednesday, helped by higher sales of its top-selling diabetes drug, Trulicity, and lower tax expense. Net income rose to $1.25 billion, or $1.37 per share, in the quarter ended Sept. 30, from $1.15 billion, or $1.12 per share, a year earlier. Revenue rose 3.2% to $5.48 billion.\n\nEli Lilly reports 9% rise in third-quarter profit", "description": "Eli Lilly reports 9% rise in third-quarter profit", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEF9M0TD_L.jpg", "published_at": "2019-10-23"}